Key result
High-dose furosemide in refractory congestive heart failure improved functional class in 17 of 20 patients and achieved a mean weight reduction of 7.3 kg over 10 days.
Why the study?
Does high-dose IV furosemide improve clinical status and fluid balance in patients with refractory congestive heart failure?
Observational (n=20)
Does high-dose IV furosemide improve clinical status and fluid balance in patients with refractory congestive heart failure?
High-dose IV furosemide is effective for rapid fluid removal and symptom improvement in patients with refractory congestive heart failure.
Answers are grounded in this paper and cite their sources.
High-dose furosemide in refractory NYHA IV HF warrants caution; leaves open need for RCTs before practice change.
High-dose firosemide is considered effective in primary renal sodium retention but is not generally recommended in congestive heart failure. In order to evaluate efficacy and safety of high-dose furosemide (greater than 500 mg/day), the authors studied 20 patients (pts) resistant to therapy (including furosemide less than 500 mg/day) selected from 161 pts admitted for chronic heart failure. All refractory pts (15 men and 5 women, mean age sixty +/- 12 years) were in NYHA class IV and showed hyponatremia (130 +/- 5 mEq/L) and impaired renal function (BUN 31 +/- 14 mg/dL, serum creatinine 1.3 +/- 0.3 mg/dL and BUN/creatinine ratio 23 +/- 7). In addition to digitalis, dopamine, angiotensin-converting enzyme inhibitors, or vasodilators, IV high-dose furosemide (775 +/- 419 mg/day, 500-2000) was given for ten +/- five days under daily clinical and laboratory monitoring. Three pts died of low-output syndrome while 16 pts were upgraded to NYHA class III and 1 pt to class II; a mean weight reduction of 7.3 +/- 2.9 kg in ten + five days (0.80 +/- 0.4 kg/day) and a mean diuresis increase of 88 +/- 57% occurred. The maximal dose of furosemide did not correlate with serum creatinine but did correlate with BUN/creatinine ratio (r = 0.78, p less than .001). Pts were discharged on with chronic heart failure, and 43% in the subgroup in NYHA class IV with hyponatremia. High dose furosemide was effective for rapid removal of excess water and salt in "furosemide-resistant" congestive heart failure. The relationship between renal impairment and maximal furosemide doses seems to confirm the role of renal pharmacokinetics in the appearance of furosemide resistance.
No takes yet. Share an insight, caveat, or question.
Marangoni et al. (1990) conducted an observational in Refractory congestive heart failure (n=20). High-dose furosemide was evaluated on Efficacy and safety (NYHA class improvement, weight reduction, diuresis). High-dose furosemide in refractory congestive heart failure improved functional class in 17 of 20 patients and achieved a mean weight reduction of 7.3 kg over 10 days.
Synapse has enriched 10 related papers. Consider them for comparative context: